Search - tctmd.com

Displaying 521 - 540 of 704

Sort: Relevancy | Date

Presentation TCT 2014

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Susheel Kodali

September 14, 2014

Presentation TCT 2014

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Ronald M. Lazar

September 14, 2014

Presentation TCT 2014

Strokes After TAVR II: Management Considerations (Current and Future)

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Nicolas M. van Mieghem

September 14, 2014

Presentation TCT 2014

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb

September 14, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

PFO Closure for Stroke: A Call to Revise the Guidelines

September 14, 2014

News Conference News TCT 2014

PCI for CTO Ups Survival vs. Medical Therapy, CABG

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

Presentation TCT 2014

Current Status of Acute Stroke Therapy: Trials, Tribulations, and Practical Issues

Presenter: Leo Nelson Hopkins, Sriram S. Iyer, Zvonimir Krajcer, Adnan Siddiqui

September 13, 2014

Presentation TCT 2014

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Sanjay Kaul

September 13, 2014

Presentation TCT 2014

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, John D. Carroll

September 13, 2014

Presentation TCT 2014

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, David E. Thaler

September 13, 2014

Presentation TCT 2014

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

Presenter: Matthew J. Price, Mark Reisman, Sheldon Goldberg, Abel Romero-Corral

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

Presentation TCT 2013

Thromboembolic Stroke: Vascular Anatomy, Histology, and Differences From Acute Myocardial Infarction

Presenter: Joey English

October 31, 2013

Presentation TCT 2013

Emergency Stroke Care Including Parallels with Acute MI

Presenter: Edward Jauch

October 31, 2013

Presentation TCT 2013

The Multidisciplinary Stroke Center of the Future

Presenter: Michael Jaff

October 31, 2013

Advertisement

Paravalvular Regurgitation After TAVR I: Incidence, Etiologies, Diagnostic Considerations, Clinical Impact, and Treatment Alternatives

Neurocognitive Functional Assessment After TAVR: Methodologies and Clinical Importance

Strokes After TAVR II: Management Considerations (Current and Future)

Strokes After TAVR I: Incidence (Past and Present) and Multifactorial Origin

TCT Course Director Outlines Current TAVR Controversies

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

PFO Closure for Stroke: A Call to Revise the Guidelines

PCI for CTO Ups Survival vs. Medical Therapy, CABG

Lively Debate on Use of TAVR for Lower-Risk Patients

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Current Status of Acute Stroke Therapy: Trials, Tribulations, and Practical Issues

The Clinical Trialists Perspective on the Evidence and Certainty: How Should It Influence Regulatory Decisions, Clinical Practice, and Guidelines?

Dissecting the Evidence: Is There Anyone with Stroke Who Can Benefit from PFO Closure?

ASA/AHA Guidelines 2014: PFO Closure for Cryptogenic Stroke Is Now Class III LOE A! Is This the Final Word from the Neurology Community?

Meta-analyses of PFO Closure Trials for Stroke: What Is the Evidence?

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Thromboembolic Stroke: Vascular Anatomy, Histology, and Differences From Acute Myocardial Infarction

Emergency Stroke Care Including Parallels with Acute MI

The Multidisciplinary Stroke Center of the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content